These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2179769

  • 1. [Effects of ticlopidine on platelet function at rest and after exercise in patients with previous myocardial infarct. An acute crossover double-blind study].
    Tullio D, Valerio A, Ottaviano MA, Di Guglielmo L, Accettura P, Caraceni CE, Sclocco T.
    Minerva Med; 1990; 81(1-2):87-92. PubMed ID: 2179769
    [Abstract] [Full Text] [Related]

  • 2. The effect of ticlopidine on platelet functions in acute myocardial infarction. A double blind controlled trial.
    Knudsen JB, Kjøller E, Skagen K, Gormsen J.
    Thromb Haemost; 1985 Jun 24; 53(3):332-6. PubMed ID: 3901391
    [Abstract] [Full Text] [Related]

  • 3. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation.
    Goto S, Tamura N, Sakakibara M, Ikeda Y, Handa S.
    Platelets; 2001 Nov 24; 12(7):406-14. PubMed ID: 11674857
    [Abstract] [Full Text] [Related]

  • 4. Prothrombotic responses to exercise are little influenced by clopidogrel treatment.
    Perneby C, Wallén NH, Hu H, Li N, Hjemdahl P.
    Thromb Res; 2004 Nov 24; 114(4):235-43. PubMed ID: 15381386
    [Abstract] [Full Text] [Related]

  • 5. Effects of ticlopidine of platelet function in men with stable angina pectoris.
    Berglund U, von Schenck H, Wallentin L.
    Thromb Haemost; 1985 Dec 17; 54(4):808-12. PubMed ID: 3911481
    [Abstract] [Full Text] [Related]

  • 6. Modulation of plasma fibrinogen levels by ticlopidine in healthy volunteers and patients with stable angina pectoris.
    de Maat MP, Arnold AE, van Buuren S, Wilson JH, Kluft C.
    Thromb Haemost; 1996 Aug 17; 76(2):166-70. PubMed ID: 8865524
    [Abstract] [Full Text] [Related]

  • 7. Platelet function in clopidogrel-treated patients with acute coronary syndrome.
    Sibbing D, von Beckerath O, Schömig A, Kastrati A, von Beckerath N.
    Blood Coagul Fibrinolysis; 2007 Jun 17; 18(4):335-9. PubMed ID: 17473574
    [Abstract] [Full Text] [Related]

  • 8. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
    Kitai T, Nishikawa M, Tanigawa T, Okinaka T, Wada H, Shiku H, Ikeda Y, Ito M, Isaka N, Nakano T.
    Am Heart J; 2001 Aug 17; 142(2):E1. PubMed ID: 11479480
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibitory effects of ticlopidine on platelet function as assessed by three different methods.
    Cuyun-Lira O, Kaneko M, Takafuta T, Satoh K, Ohnishi M, Yatomi Y, Ozaki Y.
    Eur J Pharm Sci; 2007 Jan 17; 30(1):21-5. PubMed ID: 17070023
    [Abstract] [Full Text] [Related]

  • 12. Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood.
    Heptinstall S, May JA, Glenn JR, Sanderson HM, Dickinson JP, Wilcox RG.
    Thromb Haemost; 1995 Nov 17; 74(5):1310-5. PubMed ID: 8607115
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US.
    Circulation; 2007 Jun 26; 115(25):3156-64. PubMed ID: 17562955
    [Abstract] [Full Text] [Related]

  • 14. Development of large platelet aggregates from small aggregates as determined by laser-light scattering: effects of aggregant concentration and antiplatelet medication.
    Tohgi H, Takahashi H, Watanabe K, Kuki H, Shirasawa Y.
    Thromb Haemost; 1996 May 26; 75(5):838-43. PubMed ID: 8725733
    [Abstract] [Full Text] [Related]

  • 15. Relation of platelet aggregation and fibrinogen levels to advancing age in aspirin- and thienopyridine-treated patients.
    Koltai K, Feher G, Kenyeres P, Lenart I, Alexy T, Horvath B, Marton Z, Kesmarky G, Toth K.
    Clin Hemorheol Microcirc; 2008 May 26; 40(4):295-302. PubMed ID: 19126992
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Effect of the acetylosalicyd acid (ASA) and ticlopidine therapy on clinical condition and parameters of blood platelets in patients with peripheral arterial occlusive disease (PAOD)].
    Leo W, Westrych R, Bissinger A, Okraszewski J, Baj Z.
    Pol Merkur Lekarski; 2007 Nov 26; 23(137):335-9. PubMed ID: 18361314
    [Abstract] [Full Text] [Related]

  • 18. Effects of recombinant human erythropoietin on antiplatelet action of aspirin and clopidogrel in healthy subjects: results of a double-blind, placebo-controlled randomized trial.
    Tang YD, Rinder HM, Katz SD.
    Am Heart J; 2007 Sep 26; 154(3):494.e1-7. PubMed ID: 17719296
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome.
    Xiao Z, Théroux P.
    J Am Coll Cardiol; 2004 Jun 02; 43(11):1982-8. PubMed ID: 15172401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.